Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide for Fluid Status and Residual Renal Function in CAPD
NCT00936923Phase 3Withdrawn
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of furosemide in end stage renal disease (ESRD) (3 arms), sponsored by Sun Yat-sen University. Primary endpoints: Residual renal function and Urine volume. Planned start Jun 2008; status: withdrawn.
02
Drugs
furosemide
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT00936923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936923.